I13004—Immunology/ Rheumatology

Contact:

Mentor/Principal InvestigatorRobert P. Kimberly, M.D. Professor  Mailing address: SHEL 176, 1530 3RD AVENUE S, BIRMINGHAM AL 35294-2182  Telephone: (205) 934-0245  E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Postdoctoral Position Available:  Autoimmunity and Immunologic Mechanisms

Research opportunities are available in cellular and molecular immunology; genetic organization and variation of immune response genes; structure and function of immunoglobulins; transgenic models of immune function; host responses to infectious agents; transplantation immunology; and neuroimmunology.

The primary emphasis of the program is the unraveling of pathogenetic mechanisms operative in diseases of immune etiology. Mentors involved in both their own research programs and in the care of patients with autoimmune and immune-mediate inflammatory diseases provide an opportunity for translational work between basic and applied immunology. Opportunities in human biology and disease are available in autoimmune and immune-mediated inflammatory diseases, immunodeficiencies, malignant diseases, host-defense defense including vaccine development, and transplantation immunology. Outstanding investigator-based and core-based facilities are available. Resources include state-of-the-art high-speed flow cytometry, high resolution imaging (confocal, FRET, standard and cryo-electron microscopy), nucleic acid and protein sequencing, hybridoma/phage display antibody production, and transgenic/ES cell mouse facilities.

Postdoctoral trainees with an M.D., Ph.D., or equivalent terminal degree are selected on the basis of prior academic and research performance, letters of recommendation, and personal interviews. Successful candidates will demonstrate strong commitment to a research and teaching career in academic immunology. For further information, please contact Dr. Robert Kimberly, E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .

UAB News

  • Becker’s Hospital Review has named the UAB Comprehensive Cancer Center as one of the “100 Hospitals and Health Systems With Great Oncology Programs.” Becker’s Hospital Review has named the UAB Comprehensive Cancer Center as one of the nation’s “100 Hospitals and Health Systems With Great Oncology Programs.” The UAB Cancer Center, the only one from the state of Alabama, was selected for the 2014 edition of its list for leading the way in quality patient care,...

  • A 2010 study by researchers at the University of Alabama at Birmingham found that among a group of more than 100 premenopausal women, fat was significantly reduced in those who consumed the most calcium-rich foods.

UAB Research News

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...

  • UAB School of Nursing's federally funded study shows both the patient and caregiver benefit from early palliative care.The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators. The patient outcomes from the study, known as ENABLE III, were presented June 3 at the American Society of...